Vis enkel innførsel

dc.contributor.authorGuo, Fanjia
dc.contributor.authorCai, Jingyi
dc.contributor.authorJia, Yanli
dc.contributor.authorWang, Jiawei
dc.contributor.authorJakšić, Nenad
dc.contributor.authorKövi, Zsuzsanna
dc.contributor.authorŠagud, Marina
dc.contributor.authorWang, Wei
dc.date.accessioned2022-05-03T14:44:20Z
dc.date.available2022-05-03T14:44:20Z
dc.date.created2020-11-11T13:39:56Z
dc.date.issued2020
dc.identifier.issn1471-244X
dc.identifier.urihttps://hdl.handle.net/11250/2994011
dc.description.abstractBackground Affective disorders, such as major depressive (MDD), bipolar I (BD I) and II (BD II) disorders, are overlapped at a continuum, but their exact loci are not clear. The self-reports from patients with affective disorders might help to clarify this issue. Methods We invited 738 healthy volunteers, 207 individuals with BD I, 265 BD II, and 192 MDD to answer a 79 item-MATRIX about on-going affective states. Results In study 1, all 1402 participants were divided random-evenly and gender-balanced into two subsamples; one subsample was used for exploratory factor analysis, and another for confirmatory factor analysis. A structure-validated inventory with six domains of Overactivation, Psychomotor Acceleration, Distraction/ Impulsivity, Hopelessness, Retardation, and Suicide Tendency, was developed. In study 2, among the four groups, MDD scored the highest on Retardation, Hopelessness and Suicide Tendency, whereas BD I on Distraction/ Impulsivity and Overactivation. Conclusion Our patients confirmed the affective continuum from Suicide Tendency to Overactivation, and described the different loci of MDD, BD I and BD II on this continuum.en_US
dc.language.isoengen_US
dc.publisherBMCen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleSymptom continuum reported by affective disorder patients through a structure validated questionnaireen_US
dc.title.alternativeSymptom continuum reported by affective disorder patients through a structure validated questionnaireen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume20en_US
dc.source.journalBMC Psychiatryen_US
dc.source.issue207en_US
dc.identifier.doi10.1186/s12888-020-02631-y
dc.identifier.cristin1846963
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal